Enveric Biosciences, Inc. ENVB 深 滬
已收盤 05-22 16:00:00 美东时间
2.21
-0.010
-0.45%
華盛通- 最 高2.36
- 今 開2.22
- 成交量 11.66万股
- 最 低 2.16
- 昨 收 2.22
- 總市值 813.70万
- 52周最高 17.64
- 市盈率 靜 --
- 換手率 3.17%
- 52周最低 1.71
- 委 比 -47.89%
- 總股本 368.19万
- 歷史最高 2700000.00
- 量 比 0.41
- 振 幅 9.01%
- 歷史最低 1.71
- 每 手 1
- 風險率 5.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enveric Biosciences shares are trading lower. The company announced preclinical in vitro results showing no photoreactive potential for EB‑003, further derisking its neuropsychiatric program.
Enveric Biosciences shares are trading lower. The company announced preclinical...
05-20 01:34
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
Trump's psychedelic drug order boosts investor interest with promise of faster reviews By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies developing the drugs that it cou
05-18 18:00
Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoY
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(1.08) per share. This is a 92.62 percent increase over losses of $(14.64) per share from the same period last year.
05-15 20:16
Enveric Biosciences Highlights Results for EB-003 In PTSD Preclinical Model; Says Previously Reported Results Support Continued Development Of EB-003 For PTSD, Other Neuropsychiatric Condition
Enveric Biosciences today highlighted preclinical data for its lead candidate, EB-003, a dual 5-HT2A and 5-HT1B modulator, in which a single dose of EB-003 significantly reduced context-induced freezing behavior one hour
05-05 20:00
Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure
The latest announcement is out from Enveric Biosciences ( ($ENVB) ). On April 1...
05-01 05:31
What's Going On With Enveric Biosciences Stock On Friday?
The FDA issues priority vouchers and clears early trials for ibogaine derivatives for using psychedelics for therapy and mental health.
04-25 02:13
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 63.0% to $0...
04-25 01:05
Enveric Biosciences Canada Granted U.S. Patent Over Carboxylated Psilocybin Derivatives And Methods Of Using
https://ppubs.uspto.gov/api/pdf/downloadPdf/12605361?requestToken=eyJzdWIiOiJiMmQyZjdhNi0yZmM0LTQ4YTItYWIxMS0wNzZhOTczYTU1MmEiLCJ2ZXIiOiI2ZTk5MmY4YS1kNmRjLTRlZGYtYTdkNy02NWZjZTkxM2E4MmMiLCJleHAiOjB9
04-22 02:46
BUZZ-Psychedelic drug developers rise after Trump signals regulatory support
BUZZ-Psychedelic drug developers rise after Trump signals regulatory support ** Shares of psychedelic drug developers rise premarket after U.S. President Donald Trump signed an executive order on Saturday, telling health regulators to speed up review of psychedelic drugs such as ibogaine and set asi
04-20 17:16
Enveric Biosciences prices $5 million at-the-market private placement at $2.25/share
Enveric Biosciences prices $5 million at-the-market private placement at $2.25/share Enveric Biosciences priced a private placement at-the-market under Nasdaq rules for 2,222,223 common shares or pre-funded warrants at USD 2.25 each. Gross proceeds expected at about USD 5 million. Offering includes
04-17 08:11
